Put companies on watchlist
MediClin AG
ISIN: DE0006595101
WKN: 659510
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

MediClin AG · ISIN: DE0006595101 · EQS - Company News (52 News)
Country: Germany · Primary market: Germany · EQS NID: 1659325
16 June 2023 12:15PM

MediClin AG: MEDICLIN focusses on innovative outpatient concepts in rehabilitation


EQS-News: MediClin AG / Key word(s): AGM/EGM
MediClin AG: MEDICLIN focusses on innovative outpatient concepts in rehabilitation

16.06.2023 / 12:15 CET/CEST
The issuer is solely responsible for the content of this announcement.


MEDICLIN focusses on innovative outpatient concepts in rehabilitation

At yesterday's General Annual Meeting of MEDICLIN Aktiengesellschaft (MEDICLIN), the chairman of the Management Board, Dr. Joachim Ramming, explained his contentedness with the past financial year 2022 thanks to increased sales in the Group and an improved Group operating result compared to the previous year.

But he also emphasized: "It wasn't just the higher capacity utilisation figures, but also our stringent cost control. As a result, we were able to absorb at least part of the cost increases caused by the geopolitical general conditions in 2022.”

The healthcare industry is facing major challenges

As far as the business development of the current financial year is concerned, the Management Board is satisfied with the development of capacity utilisation, but expressly referred to the current challenges, in particular the shortage of skilled workers. Tino Fritz, CFO of MEDICLIN, said: “One of the challenges is the reforms that have been passed or are being discussed in the healthcare system. They essentially affect the acute sector and thus part of our business but will also have an impact on the rehabilitation sector and thus on our largest segment.”

Sustainable concepts in rehabilitation

Dr. York Dhein, Member of the Management Board, whose responsibilities include the rehabilitation segment, sees opportunities here: "We see two developments: on the one hand, an increasing demand for more outpatient and digitally supported offers and, on the other hand, an increasing need for inpatient rehabilitation near home and in the same clinic, in where the acute treatment has already taken place - the keywords here are a continuous care process and quality assurance. Good opportunities to make our core competence rehabilitation fit for the future.”

Portfolio adjustments to the structural changes in the healthcare market

"The diverse changes in our market require a flexible handling of our skills and the determination of new application possibilities," explained Dr. Ramming. In its core business, rehabilitation, MEDICLIN will develop new offers and become more flexible, more outpatient and more digital.

In the acute segment, it will be a matter of thinking about changes in the range of services, cooperation and, if necessary, portfolio changes in order to be able to ensure comprehensive acute care with high medical quality in a region at the same time.

Information on the Annual General Meeting

At the Annual General Meeting of MEDICLIN Aktiengesellschaft, 92.83% of the share capital was represented. The actions of the Management Board and the Supervisory Board for 2022 were approved with majorities of 98.06% and 97.96% respectively. With a large majority of 96.70%, the Annual General Meeting approved the remuneration report for the Management Board and the Supervisory Board. The Annual General Meeting took place as a face-to-face event in Offenburg, the company’s registered office.

 

About MEDICLIN

MEDICLIN includes 32 clinics, six care facilities and ten medical care centres. The Group has around 8,300 beds/care places and employs around 10,000 people. In a strong network, MEDICLIN offers the patient integrative care from the first visit to the doctor through the operation and subsequent rehabilitation to outpatient aftercare. Doctors, therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people in need of care according to their individual needs and personal needs.

MEDICLIN ─ a company of the Asklepios Group. www.mediclin.de



16.06.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-326
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1659325

 
End of News EQS News Service

1659325  16.06.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1659325&application_name=news&site_id=boersengefluester_html
Visual performance / price development - MediClin AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.